| 2025-10-24 |
详情>>
股本变动：
变动后总股本83461.38万股
|
| 2025-10-24 |
详情>>
业绩披露：
2026年中报每股收益34.30印度卢比,归母净利润285.49亿印度卢比,同比去年增长7.84%
|
| 2025-07-23 |
详情>>
业绩披露：
2026年一季报每股收益17.04印度卢比,归母净利润141.78亿印度卢比,同比去年增长1.85%
|
| 2025-06-06 |
详情>>
业绩披露：
2023年年报每股收益54.28印度卢比,归母净利润450.67亿印度卢比,同比去年增长91.22%
|
| 2025-06-06 |
详情>>
业绩披露：
2025年年报每股收益67.88印度卢比,归母净利润565.44亿印度卢比,同比去年增长1.54%
|
| 2025-01-23 |
详情>>
业绩披露：
2025年三季报(累计)每股收益48.75印度卢比,归母净利润406.06亿印度卢比,同比去年增长-4.71%
|
| 2024-11-05 |
详情>>
业绩披露：
2025年中报每股收益31.79印度卢比,归母净利润264.73亿印度卢比,同比去年增长-8.16%
|
| 2024-10-16 |
详情>>
拆分方案：
每1.0000股拆分成5.0000股
|
| 2024-07-29 |
详情>>
业绩披露：
2025年一季报每股收益83.59印度卢比,归母净利润139.20亿印度卢比,同比去年增长-0.75%
|
| 2024-07-03 |
股东大会：
将于2024-07-29召开股东大会
会议内容 ▼▲
- 1.To receive, consider and adopt the Audited Financial Statements(Standalone and Consolidated)of the Company for the financial year ended March 31, 2024, together with the Reports of the Board of Directors and Auditors thereon.
2.To declare dividend of 40/- per equity share for the financial year ended March 31,2024.
3.To re-appoint Mr. K Satish Reddy (DIN: 00129701), as a Director, who retires by rotation,and being eligible offers himself for re-appointment.
|
| 2024-06-12 |
详情>>
业绩披露：
2024年年报每股收益334.65印度卢比,归母净利润556.84亿印度卢比,同比去年增长23.56%
|
| 2024-05-07 |
财报披露：
美东时间 2024-05-07 盘前发布财报
|
| 2024-01-30 |
详情>>
业绩披露：
2024年三季报(累计)每股收益256.17印度卢比,归母净利润426.14亿印度卢比,同比去年增长20.12%
|
| 2023-10-30 |
详情>>
业绩披露：
2024年中报每股收益173.36印度卢比,归母净利润288.25亿印度卢比,同比去年增长25.30%
|
| 2022-07-07 |
股东大会：
将于2022-07-29召开股东大会
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-07-02 |
股东大会：
将于2021-07-28召开股东大会
会议内容 ▼▲
- ORDINARY BUSINESS:
1.To receive, consider and adopt the financial statements (standalone and consolidated) of the Company for the year ended March 31, 2020, together with the reports of the board of directors and auditors thereon.
2.To declare dividend on the equity shares for the financial year 2020-21.
3.To reappoint Mr. G V Prassad (DIN: 00057433), as a director, who retires by rotation, and being elligible offers himself for the reappointment.
4.To reappoint statutory auditors and fix their remuneration
SPECIAL BUSINESS:
5.To ratify their remuneration payable to coast auditors, M/s. Sagar&Associates, cost accountants for the financial year ending March 31, 2022
|
| 2020-07-06 |
股东大会：
将于2020-07-30召开股东大会
会议内容 ▼▲
- ORDINARY BUSINESS:
1.To receive, consider and adopt the financial statements (standalone and consolidated) of the Company for the year ended 31 March 2020, including the audited balance sheet as at 31 March 2020 and the statement of profit and loss of the Company for the year ended on that date along with the reports of the board of directors and auditors thereon.
2.To declare dividend on the equity shares for the financial year 2019-20.
3.To reappoint Mr. K Satish Reddy (DIN: 00129701), as a director, who retires by rotation, and being elligible offers himself for the reappointment.
SPECIAL BUSINESS:
4.REAPPOINTMENT OF MR. G V PRASAD (DIN: 0057433) AS WHOLE-TIME DIRECTOR DESIGNATED AS CP-CHAIRMAN AND MANAGING DIRECTOR.
5.TO APPROVE THE CONTINUANTION OF DIRECTORSHIP OF MR. PRASAD R MENON (DIN:00005078), INDEPENDENT DIRECTOR, IN TERMS OF REGULATION 17(1A) OF THE SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015.
6.TO RATIFY THE REMUNERATION PAYABLE TO COST AUDITORS, M/S. SAGAR & ASSOCIATES, COST ACCOUNTANTS FOR THE FINANCIAL YEAR ENDING 31 MARCH 2021.
|
| 2019-07-05 |
股东大会：
将于2019-07-30召开股东大会
会议内容 ▼▲
- ORDINARY BUSINESS:
1.To receive, consider and adopt the financial statements (standalone and consolidated) of the Company for the year ended 31 March 2019, including the audited balance sheet as at 31 March 2019 and the statement of profit and loss of the Company for the year ended on that date along with the reports of the board of directors and auditors thereon.
2.To declare dividend on the equity shares for the financial year 2018-19.
3.To reappoint Mr. G V Prasad (DIN: 00057433), who retires by rotation, and being eligible offers himself for the reappointment.
SPECIAL BUSINESS:
4.REAPPOINTMENT OF MR. SPIDAR IYENGAR (DIN: 00278512) AS AN INDEPENDENT DIRECTOR FOR A SECOND TERM OF FOUR YEAR, IN TERMS OF SECTION 149 OF THE COMPANIES ACT, 2013 AND REGULATION 17（1A） OF THE SECURITIES AND EXCHANGE BOARD OF INDIA （LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS） REGULATIONS, 2015.
5.REAPPOINTMENT OF MS. KALPANAMORPARIA (DIN: 00046081) AS AN INDEPENDENT DIRECTOR FOR A SECOND TERM OF FOUR YEAR, IN TERMS OF SECTION 149 OF THE COMPANIES ACT, 2013 AND REGULATION 17（1A） OF THE SECURITIES AND EXCHANGE BOARD OF INDIA （LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS） REGULATIONS, 2015.
6.APPOINTMENT OF MR. LEO PURI (DIN: 01764813) AS AN INDEPENDENT DIRECTOR IN TERMS OF SECTION 149 OF THE COMPANIES ACT, 2013.
7.APPOINTMENT OF MS. SHIKHA SHARMA (DIN: 00043265) AS AN INDEPENDENT DIRECTOR IN TERMS OF SECTION 149 OF THE COMPANIES ACT, 2013.
8.APPOINTMENT OF MR. ALLAN OBERMAN (DIN: 08393837) AS AN INDEPENDENT DIRECTOR IN TERMS OF SECTION 149 OF THE COMPANIES ACT, 2013.
9.TO RATIFY THE REMUNERATION PAYABLE TO COST AUDITORS, M/S. SAGAR & ASSOCIATES, COST ACCOUNTANTS FOR THE FINANCIAL YEAR ENDING 31 MARCH 2020.
|
| 2018-09-24 |
股东大会：
将于2018-11-19召开股东大会
会议内容 ▼▲
- 1.the acquisition of the entire share capital of Mazor by subsidiaries of Medtronic plc, an Irish public limited company ("Medtronic") (namely, Given Imaging Ltd., a company organized under the laws of the State of Israel ("Parent 1"), Oridion Medical 1987 Ltd., a company organized under the laws of the State of Israel ("Parent 2"), Oridion Systems Ltd., a company organized under the laws of the State of Israel ("Parent 3"), Covidien Israel Holdings Ltd., a company organized under the laws of the State of Israel ("Parent 4" and together with Parent 1, Parent 2 and Parent 3, collectively and individually, the "Parent")) (other than the share capital of Mazor held by Covidien Group S.a.r.l, a Luxembourg company and a wholly-owned subsidiary of Medtronic ("CovLux")), pursuant to the Agreement and Plan of Merger, dated as of September 20, 2018 (as it may be amended from time to time, the "Merger Agreement"), through the merger of Belinom Ltd., a company organized under the laws of the State of Israel and wholly-owned by Parent ("Merger Sub") with and into Mazor, so that following such merger, Merger Sub will cease to exist and Mazor will be collectively wholly owned by Parent and CovLux (the "Merger");
2.the Merger Agreement;
3.the consideration to be received by the shareholders of Mazor in the merger, consisting of US$29.25 per share in cash, without interest and less any applicable withholding taxes, for each ordinary share of Mazor owned immediately prior to the effective time of the merger (the "Merger Consideration");
4.in connection with the renewal of the directors' and officers' liability insurance policy, the amendment of the Compensation Policy such that the relevant premium limit shall be increased;
5.the purchase by Mazor of a run-off directors' and officers' liability insurance policy for a period of seven years following the effective time of the Merger, as permitted under the Merger Agreement; (vi) the accelerated vesting of (if unvested) and cancellation of each outstanding option to purchase ordinary shares of Mazor (including those granted to Mazor's officers and directors) in exchange for the right to receive a lump sum cash payment equal to the product of the excess, if any, of the Merger Consideration over the applicable per share exercise price of such option, and the total number of ordinary shares underlying such option, without interest and subject to applicable withholding taxes;
6.the accelerated vesting of (if unvested) and cancellation of each outstanding RSU (including those granted to Mazor's officers and directors) in exchange for the right to receive a lump sum cash payment (to the extent such payment does not trigger taxes under Section 409A of the Internal Revenue Code of 1986, as amended) equal to the product of the Merger Consideration and the number of ordinary shares subject to such RSU, without interest and subject to applicable withholding taxes;
7.the payment by Mazor of special transaction bonuses to officers in Mazor in connection with the merger transaction and subject to the completion of the Merger, as permitted under the Merger Agreement;
8.all other transactions and arrangements contemplated by the Merger Agreement, a copy of which is attached to Mazor's Report of Foreign Private Issuer on Form 6-K furnished to the U.S. Securities and Exchange Commission (the "SEC") on September 24, 2018. We refer to items (i) through (ix) in this proposal as the "Merger Proposal".
|
| 2018-07-06 |
股东大会：
将于2018-07-27召开股东大会
会议内容 ▼▲
- ORDINARY BUSINESS:
1.To receive, consider and adopt the financial statements (standalone and consolidated) of the Company for the year ended 31 March 2018, including the audited balance sheet as at 31 March 2018 and the statement of profit and loss of the Company for the year ended on that date along with the reports of the board of directors and auditors thereon.
2.To declare dividend on the equity shares for the financial year 2017-18.
3.To reappoint Mr. K Satish Reddy (DIN: 00129701), who retires by rotation, and being eligible offers himself for the reappointment.
SPECIAL BUSINESS:
4.REAPPOINTMENT OF MR. ANUPAM PURI (DIN: 00209113) AS AN INDEPENDENT DIRECTOR FOR A SECOND TERM OF ONE YEAR PERIOD, IN TERMS OF SECTION 149 OF THE COMPANIES ACT, 2013.
5.APPOINTMENT OF MR. PRASAD R MENON (DIN: 00005078) AS AN INDEPENDENT DIRECTOR IN TERMS OF SECTION 149 OF THE COMPANIES ACT, 2013.
6.APPROVAL OF ‘DR. REDDY’S EMPLOYEES STOCK OPTION SCHEME, 2018’ (‘2018 ESOS’).
7.GRANT OF STOCK OPTIONS TO THE EMPLOYEES OF THE SUBSIDIARY COMPANIES OF THE COMPANY UNDER ‘DR. REDDY’S EMPLOYEES STOCK OPTION SCHEME, 2018’ (‘2018 ESOS’).
8.IMPLEMENTATION OF THE ‘DR. REDDY’S EMPLOYEES STOCK OPTION SCHEME, 2018’ (‘2018 ESOS’) THROUGH DR. REDDY’S EMPLOYEES ESOS TRUST.
9.AUTHORISATION TO DR. REDDY’S EMPLOYEES ESOS TRUST (ESOS TRUST) FOR SECONDARY ACQUISITION OF EQUITY SHARES FOR THE PURPOSE OF STOCK OPTIONS.
10.TO RATIFY THE REMUNERATION PAYABLE TO COST AUDITORS, M/S. SAGAR & ASSOCIATES, COST ACCOUNTANTS FOR THE FINANCIAL YEAR ENDING 31 MARCH 2019.
|
| 2017-08-04 |
除权日：
美东时间 2017-07-13 每股派息0.29美元
|
| 2017-07-07 |
股东大会：
将于2017-07-28召开股东大会
会议内容 ▼▲
- ORDINARY BUSINESS:
1.To receive, consider and adopt the financial statements (standalone and consolidated) of the company for the year ended 31 March 2017, including the audited balance sheet as at 31 March 2017 and the statement of profit and loss of the company for the year ended on that date along with the reports of the board of directors and auditors thereon.
2.To declare dividend on the equity shares for the financial year 2016-17.
3.To re-appoint Mr. G V Prasad (DIN: 00057433), who retires by rotation and, being eligible, offers himself for the re-appointment.
4.To ratify appointment of statutory auditors and fix their remuneration.
“RESOLVED THAT pursuant to the provisions of sections 139, 142 and other applicable provisions, if any, of the Companies Act, 2013 and their corresponding rules, pursuant to the recommendations of the audit committee and the resolution passed by the members at their 32nd annual general meeting (AGM) held on 27 July 2016, the appointment of M/s. S R Batliboi & Associates LLP, Chartered Accountants (Firm Registration No. 101049W/E300004), who have confirmed their eligibility in terms of the provisions of section 141 of the Companies Act, 2013 and rule 4 of the Companies (Audit and Auditors) Rules, 2014, as statutory auditors, to hold office upto the conclusion of 34th AGM, be and is hereby ratified at such remuneration and out of pocket expenses, as may be decided by the board of directors of the company.”
SPECIAL BUSINESS:
5.RE-APPOINTMENT OF MR. K SATISH REDDY (DIN: 00129701) AS WHOLE-TIME DIRECTOR DESIGNATED AS CHAIRMAN.
|
| 2016-06-03 |
除权日：
美东时间 2016-07-14 每股派息0.30美元
|
| 2015-06-22 |
除权日：
美东时间 2015-07-08 每股派息0.31美元
|
| 2014-06-09 |
除权日：
美东时间 2014-08-01 每股派息0.29美元
|
| 2013-06-05 |
除权日：
美东时间 2013-07-10 每股派息0.26美元
|
| 2012-06-09 |
除权日：
美东时间 2012-06-27 每股派息0.25美元
|
| 2011-06-18 |
除权日：
美东时间 2011-06-29 每股派息0.25美元
|
| 2010-06-16 |
除权日：
美东时间 2010-06-30 每股派息0.22美元
|